Compare IDN & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDN | ORMP |
|---|---|---|
| Founded | 1994 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.6M | 104.6M |
| IPO Year | 1999 | N/A |
| Metric | IDN | ORMP |
|---|---|---|
| Price | $6.88 | $2.88 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.33 | N/A |
| AVG Volume (30 Days) | 194.8K | ★ 226.4K |
| Earning Date | 11-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 838.25 |
| EPS | 0.01 | ★ 1.03 |
| Revenue | ★ $21,968,000.00 | $2,000,000.00 |
| Revenue This Year | $12.25 | N/A |
| Revenue Next Year | $11.20 | N/A |
| P/E Ratio | $666.09 | ★ $2.85 |
| Revenue Growth | ★ 14.20 | N/A |
| 52 Week Low | $2.17 | $1.82 |
| 52 Week High | $7.48 | $3.20 |
| Indicator | IDN | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 59.62 | 59.49 |
| Support Level | $6.25 | $2.66 |
| Resistance Level | $7.06 | $3.19 |
| Average True Range (ATR) | 0.37 | 0.14 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 79.18 | 46.30 |
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.